www.fdanews.com/articles/100833-fda-approval-of-easypod-new-electronic-growth-hormone-injection-device
FDA Approval of Easypod: New Electronic Growth Hormone Injection Device
November 8, 2007
Merck Serono, a division of Merck KGaA, announced that its U.S. affiliate, EMD Serono, Inc. received U.S. Food and Drug Administration (FDA) approval of easypod, an innovative delivery system for the administration of Saizen [somatropin (rDNA origin) for injection], a treatment for growth hormone deficiency.
Merck